Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review

World J Transplant. 2018 Jun 28;8(3):75-83. doi: 10.5500/wjt.v8.i3.75.

Abstract

Aim: To investigate the relationship between post-liver transplantation (LT) glycemic control and LT outcomes.

Methods: A qualitative systematic review on relevant prospective interventions designed to control glucose levels including insulin protocols. Studies investigating an association between glycemic control and post-LT outcomes such as mortality, graft rejection, and infection rate were reviewed. PubMed, EMBASE, and other databases were searched through October 2016.

Results: Three thousands, six hundreds and ninety-two patients from 14 studies were included. Higher mortality rate was seen when blood glucose (BG) ≥ 150 mg/dL (P = 0.05). BG ≥ 150 mg/dL also led to higher rates of infection. Higher rates of graft rejection were seen at BG > 200 mg/dL (P < 0.001). Mean BG ≥ 200 mg/dL was associated with more infections (P = 0.002). Nurse-initiated protocols and early screening strategies have shown a reduction in negative post-LT outcomes.

Conclusion: Hyperglycemia in the perioperative period is associated with poor post-LT outcomes. Only a few prospective studies have designed interventions aimed at managing post-LT hyperglycemia, post-transplant diabetes mellitus (PTDM) and their impact on post-LT outcomes.

Keywords: Diabetes; Liver transplant; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Outcomes.